Cargando…
Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study
Stereotactic body radiotherapy (SBRT) for centrally-located lung tumors remains a challenge because of the increased risk of treatment-related adverse events (AEs), and uncertainty around prescribing the optimal dose. The present study reported the results of central tumor SBRT with 56 Gy in 7 fract...
Autores principales: | Aoki, Shuri, Yamashita, Hideomi, Haga, Akihiro, Ota, Takeshi, Takahashi, Wataru, Ozaki, Sho, Nawa, Kanabu, Imae, Toshikazu, Abe, Osamu, Nakagawa, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126178/ https://www.ncbi.nlm.nih.gov/pubmed/30214585 http://dx.doi.org/10.3892/ol.2018.9188 |
Ejemplares similares
-
Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients
por: Aoki, Shuri, et al.
Publicado: (2020) -
Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy()
por: Takahashi, Wataru, et al.
Publicado: (2019) -
Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates
por: Yamashita, Hideomi, et al.
Publicado: (2014) -
Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
por: Aoki, Shuri, et al.
Publicado: (2020) -
Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease
por: Yamashita, Hideomi, et al.
Publicado: (2020)